The MS Society of Canada says it will put aside $1 million aside in case a patient trial of the "liberation treatment" is ever approved.
The agency and the MS Society in the United States already have seven research projects underway. Preliminary results from those studies are expected within a few months.
If the results of those studies suggest that a human trial of the "liberation treatment" is warranted, the MS Society says the money to fund such a trial will now be at the ready.
The society said Thursday its board of directors approved the motion to reserve the money.
"Ensuring funds are available to support a Canadian trial will accelerate our ability to get definitive answers to the questions people touched by MS urgently seek," said Yves Savoie, president and CEO of the MS Society, in a news release.
At this week's health ministers' meeting in Newfoundland and Labrador, provinces and territories said it was a top priority to determine whether there was validity to the theory proposed by Italian surgeon Dr. Paolo Zamboni that blocked neck and chest veins contribute to MS.
That followed an announcement by federal Health Minister Leona Aglukkaq that an expert scientific working group would be created to monitor studies already underway.
Those experts will analyze evidence about venous blockages and their relationship with MS.
